Big Pharma Turns to Wearables to Collect Information from Drug Trial Patients
Big Pharma is turning to Fitbit and other wearables to collect information from drug trial patients. Not only will this move bring drugs to market faster, but it also provides more accurate data points (with measurable results) than self-reported surveys.